Lucía Martínez Saavedra
M.Sc. Drug Discovery, Universidad Complutense de Madrid (UCM), Universidad de Alcalá (UAH) and Universidad San Pablo CEU.
B.Sc. Chemistry, UCM.
Lucía started as a PhD student in April 2019 in the Neurodrugs Group from the Medical Chemistry Institute (CSIC). Within this project, Lucia works on the design, synthesis and characterization of new non-electrophilic inhibitors of the protein-protein interaction between Keap1 and Nrf2. These compounds will be further subjected to a biological evaluation as potential drugs for the treatment of diseases of the central nervous system, like Alzheimer’s disease.